Depression and suicidality with VMAT2 inhibitors in tardive dyskinesia A signal detection from the FDA Adverse Events Reporting System

PCN Rep. 2023 Feb 27;2(1):e79. doi: 10.1002/pcn5.79. eCollection 2023 Mar.
No abstract available